CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-29 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −594 | $17.80 | $11K | 49,817 |
| 2024-01-29 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −761 | $17.80 | $14K | 49,056 |
| 2024-01-29 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −963 | $17.80 | $17K | 48,093 |
| 2024-01-29 | Bair Teresa Brophy Chief Legal Officer | Sale | −2,053 | $17.80 | $37K | 68,979 |
| 2024-01-29 | FORD KATHLEEN Chief Operating Officer | Sale | −1,496 | $17.80 | $27K | 21,602 |
| 2024-01-29 | DALE STEPHEN Chief Medical Officer | Sale | −4,400 | $17.80 | $78K | 46,400 |
| 2024-01-29 | DALE STEPHEN Chief Medical Officer | Sale | −2,758 | $17.80 | $49K | 43,642 |
| 2024-01-24 | WILSON TROY EDWARD President and CEO | Option exercise | +6,945 | $4.80 | $33K | 7,504 |
| 2024-01-24 | WILSON TROY EDWARD President and CEO | Sale | −6,945 | $20.23 | $140K | 559 |
| 2024-01-24 | WILSON TROY EDWARD President and CEO | Option exercise | +84,107 | $6.15 | $517K | 84,666 |
| 2024-01-24 | WILSON TROY EDWARD President and CEO | Sale | −84,107 | $20.23 | $1.7M | 559 |
| 2024-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +21,250 | 50,411 | ||
| 2024-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award · Option to purchase common stock | +42,500 | 42,500 | ||
| 2024-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award | +15,000 | 15,000 | ||
| 2024-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2024-01-02 | Bair Teresa Brophy Chief Legal Officer | Grant or award | +46,250 | 71,032 | ||
| 2024-01-02 | Bair Teresa Brophy Chief Legal Officer | Grant or award · Option to purchase common stock | +92,500 | 92,500 | ||
| 2024-01-02 | FORD KATHLEEN Chief Operating Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2024-01-02 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2024-01-02 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +560,000 | 560,000 |
Page 8 of 9 · 164 trades